Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
Crossref DOI link: https://doi.org/10.1186/s12885-017-3695-5
Published Online: 2017-11-03
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gohr, Katharina
Hamacher, Alexandra
Engelke, Laura H.
Kassack, Matthias U.
Funding for this research was provided by:
Bundesministerium für Wirtschaft (BMWi) (KF2388801UL9)
